MedTrace Logo

Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

NCT01375725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-06-17

No results posted yet for this study

Summary

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

Conditions

  • Clotting Disorders

Sponsors & Collaborators

  • Universal Biosensors Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Richard Ward, Pharm.D · Harding University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01375725 on ClinicalTrials.gov